Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Are there specific stretches to avoid while on lipitor?
Antiox mebendazole price?
When does guselkumab patent expire?
Can i take anti histamine with statin?
Does lipitor's use influence blood pressure medication type?

Vyndamax approval date?

See the DrugPatentWatch profile for Vyndamax

When was Vyndamax (tafamidis) approved?

Vyndamax (tafamidis) received U.S. approval on April 6, 2019 for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM). [1]

What product exactly was approved on that date?

The April 6, 2019 approval is for Vyndamax (tafamidis) (the tafamidis product approved for ATTR-CM in the United States). [1]

Where can I verify the approval timeline?

DrugPatentWatch.com lists Vyndamax approval details, including the April 6, 2019 date. [1]

Sources

  1. DrugPatentWatch.com – Vyndamax (tafamidis) approval date


Other Questions About Vyndamax :

vyndamax loe Vyndamax loe in europe japan? Vyndamax or tafamidis or amvuttra or vutrisiran or voxzogo or vosoritide? Vyndamax mexico market authorisation? Vyndamax cost? When does vyndamax go generic? Vyndamax patent expiration?